The Global Ebola Vaccine Market Growth Accelerated By Increasing Government Initiatives

https://www.coherentmarketinsights.com/market-insight/ebola-vaccine-market-1365
Ebola Vaccine Market


The Ebola vaccine market consists of various products such as live-attenuated virus vaccine and inactivated virus vaccine used to prevent Ebola virus disease. Ebola vaccines induce an immune response in humans that protects against one or more strains of the Ebola virus. They help reduce the risk of Ebola virus infection and are considered an important tool in controlling outbreaks.

The global Ebola Vaccine Market is estimated to be valued at US$ 5.83 Bn in 2023 and is expected to exhibit a CAGR of 14% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving growth in the Ebola vaccine market is increasing government initiatives towards prevention and control of Ebola outbreaks. Several national governments and international organizations are undertaking efforts like funding research programs, conducting vaccination drives, and raising awareness regarding the disease. For instance, the United Nations has established an Ebola emergency response coordination system to assist countries in outbreak preparedness and response. Additionally, governments of developed nations are investing heavily in biotechnology companies engaged in Ebola vaccine development. This is increasing research activities and accelerating the development of novel and effective Ebola vaccines. Rising government support for prevention of Ebola is expected to boost the demand for Ebola vaccines over the forecast period.
Segment Analysis

The global Ebola vaccine market can be segmented by product type, and end-user. By product type, the market is segmented as DNA vaccines, vector vaccine, and recombinant vaccine. Recombinant vaccines
accounted for the largest market share in 2023 owing to better efficacy in generating immune responses against Ebola virus infections as compared to other alternatives. By end-user, the market is categorized as hospitals, clinics, and research institutes. Hospitals dominated the market in 2023 due to a rise in cases of Ebola virus infection, surge in number of treatment facilities for viral diseases globally.

Key Takeaways

The global Ebola Vaccine Market Size is expected to witness high growth during the forecast period of 2023-2030. Regional analysis shows that North America is the fastest growing and dominating region driven by new product launches, significant investments in research & development activities about development of Ebola vaccines by pharmaceutical companies, growing awareness about Ebola prevention in the region.

Key players operating in the Ebola vaccine market are Siegfried, Sanofi, Johnson & Johnson, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co. Siegfried recently received approval from European Commission for its innovative production process to manufacture Ebola vaccine. Sanofi's VesVax and Johnson & Johnson's ERVEBO are the only approved vaccines available in market for prevention of Ebola virus disease.

The global Ebola vaccine market is expected to witness high growth during the forecast period due to rising demand for preventive care against Ebola virus infection and epidemic outbreaks, technological advancements in vaccine development, favorable government support for critical disease treatment. North America dominated market in 2023 owing to investments in R&D, presence of key manufacturers, growing awareness about Ebola prevention. Key players are focused on approval and commercialization of innovative vaccines to strengthen market position.

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more